Publication | Open Access
<i>KCNQ2</i> encephalopathy
234
Citations
29
References
2016
Year
This study provides Class IV evidence that EZO is effective for refractory seizures in patients with epilepsy due to KCNQ2 encephalopathy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1